Yale University study links gut microbiome changes to multiple sclerosis onset. Findings highlight differences in bacterial composition, IgA antibodies, and effects of B-cell depletion therapy.

In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high ...

Stephanie Mauro, now 76 years old, has had multiple sclerosis for more than 40 years. In 2020, when COVID-19 first appeared in the United States, her condition had worsened to the point where her ...

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...